Chennai-based Take Solutions Ltd has reported a 50 per cent increase in net profit to ₹24 crore for the third quarter ended December 31, 2015 against ₹16 crore for the corresponding period last year. Revenue increased by 30 per cent to ₹248 crore (₹185 crore) as its clients in North America continued to spend on life sciences and supply chain solutions. During the quarter, the company acquired Ecron Acunova, a life sciences services player, to explore emerging vistas of Biosimilars, Regenerative Medicine and Diagnostic Imaging Agents, for ₹115 crore. It also launched PVIndia, a pharma covigilance peer network to provide a forum for the pharmaceutical industry to discuss and ideate on solutions for challenges faced, says a company press release.
HR Srinivasan, Vice-Chairman and MD, in the press release said the results reflect the success of its strategy to emerge as a 360 degree player in the domain life sciences. Our Bureau
On the Bombay Stock Exchange, the company’s share priced closed at ₹145.85, down by ₹9.50.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.